Richard P. Blumberg - Mar 1, 2024 Form 4 Insider Report for GUIDED THERAPEUTICS INC (GTHP)

Role: Director, 10%+ Owner
Signature: /s/ Richard P. Blumberg
Stock symbol: GTHP
Transactions as of: Mar 1, 2024
Transactions value $: $0
Form type: 4
Date filed: 3/22/2024, 06:04 PM
Previous filing: Dec 8, 2023
Next filing: Apr 5, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GTHP	Common stock	Other		+400K	+7.19%		5.97M	Mar 1, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GTHP	Warrants	Other		+900K	+50%		2.7M	Mar 1, 2024	Common shares	900K	$0.30	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended on September 30, 2021 and November 11, 2022. As a result of the consulting agreement Mr. Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches. The third tranche was issued on March 1, 2024 and was due 18 months after the Company obtained the requisite financing. The remaining tranche is due September 2024.

Content

On March 10, 2021, the Company entered into a consulting agreement with Richard Blumberg, which was subsequently amended on September 30, 2021 and November 11, 2022. As a result of the consulting agreement Mr. Blumberg provided $350,000 to the Company in exchange for 1,600,000 common shares and 3,600,000 warrants to acquire common shares with an exercise price of $0.30. Issuance of the common stock and warrants was predicated on the Company obtaining financing totaling a minimum of $1.0 million and Mr. Blumberg's continued service for the Company. The common stock and warrants are required to be issued in four equal tranches. The third tranche was issued on March 1, 2024 and was due 18 months after the Company obtained the requisite financing. The remaining tranche is due September 2024.